T. Rowe Price Associates »

Elevation Oncology shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Elevation Oncology (ELEV) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Elevation Oncology

Tip: Access up to 7 years of quarterly data

All positions including Elevation Oncology held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Elevation Oncology by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-12-31 $10k 17k 0.59
2024-09-30 $11k 17k 0.65
2024-06-30 $0 17k 0.00

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Alphabet Comm Stk (GOOGL)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOG)
Visa Comm Stk (V)
Tesla Comm Stk (TSLA)
Broadcom Comm Stk (AVGO)
Unitedhealth Group Comm Stk (UNH)
Netflix Comm Stk (NFLX)
Mastercard Incorporated Comm Stk (MA)
Servicenow Comm Stk (NOW)

View all positions for T. Rowe Price Associates

Top funds holding Elevation Oncology

Frazier Life Sciences Management
Tang Capital Management
Farallon Capital Management
BlackRock
BVF
Aisling Capital Management
Vanguard Group
Goldman Sachs Group
Renaissance Technologies
Geode Capital Management
State Street Corporation
Sphera Funds Management
OrbiMed Advisors
Millennium Management
Ikarian Capital

View all funds holding Elevation Oncology